Bachem acquires American Peptide Company

February 27, 2015

Bubendorf/Basel, February 27, 2015 – Bachem (SIX:BANB), the leading peptide manufacturer, announced today the forthcoming acquisition of American Peptide Company, Inc. (APC), based in California, USA. The seller ILS, Inc. (Moriya, Japan), a wholly-owned subsidiary of Otsuka Chemical Co., Ltd. (Osaka, Japan), and the buyer, Bachem Americas, Inc. (Torrance, USA) have signed a contract to transfer all shares of APC. Both parties have agreed not to disclose the terms of the deal.


At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.

View all jobs

Click here >>

Contact us


  • Please choose if you would like to receive additional email communications from Bachem:

  • Fields marked with an asterisk (*) are required

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.